Acute-phase proteins: As diagnostic tool.

Jain S, Gautam V, Naseem S. · 2011

Read Acute-phase proteins: As diagnostic tool. by Jain S, Gautam V, Naseem S. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3053509.txt.

Introduction

Jain, Gautam, and Naseem reviewed in 2011 the proteins the body floods into the blood within hours of infection, injury, or trauma. These acute phase proteins are made mainly by the liver after alarm signals arrive from the damage site. They help trap microbes, clear cell debris, neutralize harmful enzymes, and tune the immune response while repair gets under way.

Because their levels rise and fall with illness in predictable ways, the proteins double as diagnostic tools. The review lists veterinary and medical uses, from cattle lung infections and pig diseases to prostate cancer and blood cancers in people. In farm practice, a blood test for these proteins can flag sick animals before clear symptoms show. The authors present them as a cheap, early window on animal health that complements hands on examination.

Catalog record

CREATORJain S, Gautam V, Naseem S.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3053509

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Acute-phase proteins: As diagnostic tool By Sachin Jain, Vidhi Gautam, Sania Naseem Published in: Journal of Pharmacy and Bioallied Sciences DOI: 10.4103/0975-7406.76489 ABSTRACT The varied reactions of the host to infection, inflammation, or trauma are collectively known as the acute-phase response and encompass a wide range of pathophysiological responses such as pyrexia, leukocytosis, hormone alterations, and muscle protein depletion combining to minimize tissue damage while enhancing the repair process. The mechanism for stimulation of hepatic production of acute-phase proteins is by proinflammatory cytokines. The functions of positive acute-phase proteins (APP) are regarded as important in optimization and trapping of microorganism and their products, in activating the complement system, in binding cellular remnants like nuclear fractions, in neutralizing enzymes, scavenging free hemoglobin and radicals, and in modulating the host’s immune response. APP can be used as diagnostic tool in many diseases like bovine respiratory syncytial virus, prostate cancer, bronchopneumonia, multiple myeloma, mastitis, Streptococcus suis infection, starvation, or lymphatic neoplasia. Thus, acute-phase proteins may provide an alternative means of monitoring animal health. Animals undergoing external or internal challenge to their state of health mount a vigorous response including activation of both the innate and acquired immune systems. The innate immune system which covers those aspects of the host defense mechanisms not dependent on specific response, such as production of antibody, not only stimulates leukocyte activity but also effects many aspects of the host’s metabolic processes. The varied reactions of the host to infection, inflammation, or trauma are collectively known as the acute-phase response (APR) and encompass a wide range of pathophysiological responses such as pyrexia, leukocytosis, hormone alterations, and muscle protein depletion combining to minimize tissue damage while enhancing the repair process.[1] Another of these systemic responses to disease is an increase in the production by the liver of a number of plasma proteins which are known collectively as the acute-phase proteins (APP).[2–4] The APR is a very complex reaction, involving local and systemic effects. One of these effects corresponds to changes in the concentration of some plasma proteins, mainly synthesized in the liver, which are called APP. The APR is induced by protein hormones called cytokines acting as messengers between the local site of injury and the hepatocytes synthesizing the APPs. Most cytokines have multiple sources, multiple targets, and multiple functions,[5] and they have been found in a large number of animal species including mammals, birds, fish, reptiles, and starfish.[6–10] The changes in the concentrations of APPs are largely due to changes in their production by hepatocytes. The magnitude of the increases varies from about 50% in the case of C-reactive protein (CRP) and serum amyloid A (SAA). Under the influence of interleukin (IL), i.e., IL-1, IL-2, and tumor necrosis factor – alpha (TNF-α), liver cells synthesize and secrete APPs. The maximum serum concentration of APPs is typically reached within 24 to 48 h after the initiation. A decline coinciding with the recovery from the infection is seen,[11] and generally, feed-back regulations will limit the response leading to its resolution within 4–7 days after the initial stimulus if no further stimulus occurs. When the receptor triggering has repeated pulses, the APR can become chronic. Chronic inflammation (e.g., arthritis) can be perceived as a consecutive series of separate inflammatory stimuli. In such conditions, increased serum concentrations of APPs are generally observed.[12] However, the increase is lower than during acute episodes of inflammation or infection. There are also indications that the response to chronic compared to acute inflammation varies from one protein to another.[13] The three most important APPs are CRP, serum amyloid P (SAP), and SAA.[14] Many APPs, such as CRP and SAA bind to microbial cell walls and they may act as opsonins and fix complement, thus promoting the elimination of microbes. MECHANISM OF SYNTHESIS OF ACUTE PHASE PROTEINS An APR is characterized, among other things, by fever and increases the numbers of peripherals leukocytes, in particulars, increasing the numbers of circulating neutrophils and their precursors. At the same time, cellular and biochemical alterations, in particulars the coordinated synthesis, of so-called APPs or APRs by hepatocytes take place in the liver [Figure 1]. [Figure: Synthesis of acute phase proteins] REGULATION OF ACUTE PHASE REACTIONS AND SYNTHESIS OF ACUTE PHASE PROTEINS According to Beutler and Cerami,[15] the APR is stimulated by the release of cytokines such as IL-1, IL-6, and TNF-α from macrophages and monocytes at the site of inflammatory lesions or infections. Inflammatory cytokines such as IL-6, IL-1, TNF, and others such as transforming growth factor (TGF) and interferon (IFN) are produced by inflammatory cells. These proinflammatory cytokines induce local and systemic reactions.[16] These mediators are involved in cell activation of leucocytes, fibroblast, endothelial cells, and smooth muscle cells, result in a systemic release of cytokines, increase in the circulation of the cytokines, and then stimulate the hepatic APR.[17] Systemic reaction results in activation of the hypothalamus, reduction in growth hormone secretion, and a number of other physiological changes characterized by fever, anorexia, and catabolism of muscle cells. TNF-α, IL-1β, and INF-γ are crucial for the expression of inflammatory mediators such as prostaglandins and leukotrienes and they induce the production of platelet-activating factor and IL-6. After stimulation by proinflammatory cytokines, Kuffer cells in the liver produce IL-6 and present it to the hepatocytes. Thus, IL-6 is the major mediator for the hepatocytic secretion of most of the APPs. Activities are enhanced indirectly by activation of the pituitary/adrenal gland axis, which involves synthesis of adrenocorticotrophic hormone (ACTH) and subsequent production of cortisal. The increase in glucocorticoids during the APR is a result of cytokine stimulation of the pituitary–adrenal axis to produce adrenocorticotrophic hormone.[18] As a result, an increase in corticosterone, the main glucocorticoids, is observed later than the appearance of IL-6.[19] Cortisol can enhance expression of IL-6 receptors in liver cells and thus promotes IL-6-mediated synthesis of APPs. Glucocorticoids are hormone that can be involved in APR as in mammals.[20] The role of glucocorticoids in birds seems to be both stimulatory and regulatory.[19] The administration of glucocorticoids to domestic fowl can also stimulate APP synthesis hormone,[18] which suggest that glucocorticoids may work independently of cytokines. Negative regulatory loops can involve inhibition of synthesis of IL-6, IL-1, and TNF by cortisol and inhibition of the synthesis of IL-1 and TNF in monocytes by IL-6. Of all mediators participating in the induction and regulation of APP synthesis, IL-6 appears to induce the broadest spectrum of APPs whereas IL-1 and TNF only induce the synthesis of subsets of these proteins. The mechanism for stimulation of hepatic production of APPs by proinflammatory cytokines has been extensively studied. Induction of the APPs by IL-1 following binding to the IL-6 receptor causes phosphorylation and degradation of inhibitor kappa B (IKB). The inhibitor of transcription factor nuclear factor kappa B (NF-kB) leads to the release of NF-kB and subsequent activation of acute-phase gene in nucleus.[21] CLASSIFICATION OF ACUTE-PHASE PROTEINS On the basis of protein concentrations Negative acute-phase proteins The liver responds by producing a large number of APRs. At the same time, the production of a number of other proteins is reduced; these are therefore referred to as “negative” APPs. Negative APPs are albumin, transferring, transthyretin, transcortin, and retinol-binding protein. Positive acute-phase proteins Positive APPs are CRP, D-dimer protein,

Read the complete text